Recorded Webinar: Biotech Showcase Comparing Informatics Platforms
Biotech Showcase: Comparing Informatics Platforms of 2 Biotech Organizations
Recorded live March 14, 2019
Discussion on this webinar was lively and highly informed. Watch the recording below to see the Foghorn Therapeutics collaborative scientific team of David Lahr (Head of Informatics), Joe Marchionna (Research Informatics), and Johannes Voigt (Computational Chemist), together with An2h Discovery CSO Jennifer Johnston, as they reveal cutting-edge informatics workflows with CDD Vault.
In this seminar you'll learn about:
- How distributed biotechnology researchers best use CDD’s new ELN module, as well as the traditional Activity & Registration, Visualization, and Inventory capabilities.
- Learn about the more sophisticated, custom scripts which interface with CDD Vault via the Application Programming Interface (API).
- Witness the successful creation of a useful data-mart (as opposed to the more common “data swamp”), with the customized “Fog-Browser”.
- How CDD Vault plays well with an ecosystem of leading tools, including:
Featuring These Leading Scientists...
Dr. Johnston is CSO of An2H Discovery, a biotech company focused on the modulation of the Ubiquitin Pathway for critical unmet medical needs in Neurology and Oncology.
Prior to starting An2H, Dr. Johnston was the VP of Research and Head of Exploratory Research at Elan Pharmaceuticals, and also led the Parkin Project, a drug discovery program focused on the identification of specific small molecule therapeutics that modulate the activity of Parkin E3 ligase.
Dave Lahr is Director of Bioinformatics and Informatics at Foghorn Therapeutics, Inc. where he is responsible for bioinformatics enabling new target discovery and validation, as well as general research data management.
Prior to joining Foghorn, Dr. Lahr worked at the Broad Institute as part of the Center for Development of Therapeutics, and then the Connectivity Map within the Cancer Program.
Johannes H. Voigt
Johannes Voigt is Director of Computational Chemistry at Foghorn Therapeutics, where he is responsible for ligand and structure-based drug design, chemoinformatics, and decision-enabling tools.
Prior to joining Foghorn, Dr. Voigt contributed to drug discovery projects at Schering-Plough/Merck, Gilead, and CHDI. He is co-author of over 50 publications.
Joe Marchionna is Director of Research Informatics at Foghorn Therapeutics. He is responsible for the strategic implementation and management of research informatics.
Prior to joining Foghorn Therapeutics, he consulted with various biotech startups as part of the Flagship Pioneering and Third Rock Venture VC firms, and developed research systems at Constellation Pharmaceuticals, Johnson & Johnson, and Transform Pharmaceuticals.